Efficacy of Topical Cyclosporine A for Treatment and Prevention of Graft Rejection in Corneal Grafts With Previous Rejection Episodes

首次发布于 2009 年 12 月 9 日

PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects

计划入组 48 人 · 首次发布于 2014 年 5 月 5 日

A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers

计划入组 65 人 · 首次发布于 2012 年 9 月 25 日

Orilanolimab

CD19/CD3/41BB/PD-L1 antibody (Systimmune)

interferon-conjugated nanoparticle gemcitabine (Cytimmune sciences)

Syntimmune, Inc.

United States

SYSTIMMUNE INC.

United States

Systimmune, Inc.

United States

Vor Bio Secures Global Rights to Telitacicept in $4+ Billion Deal with RemeGen

FDA Clears IND for SystImmune's BL-M11D1 in Relapsed/Refractory AML

SystImmune's BL-M17D1 Antibody-Drug Conjugate Receives FDA IND Clearance for Advanced Solid Tumors